(By Barbara Feder Ostrov for California Healthline produced by Kaiser Health News)
Seven months after a controversial California law took effect requiring advance notice of planned price increases on prescription drugs, many pharmaceutical companies appear to be in compliance.
But not Eli Lilly. Continue reading article here…
This story was produced by Kaiser Health News, which publishes California Healthline, a service of the California Health Care Foundation.”
Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.